Risks and protective factors for triple negative breast cancer with a focus on micronutrients and infections

Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
Dagmar HorakovaHelena Kollarova

Abstract

Triple negative breast cancer (TNBC) is an aggressive form of breast cancer (BC) with a poor prognosis. Second, patients cannot benefit from targeted therapy, except for those with BRCA1/2 mutations, for whom poly (ADP-ribose) polymerase (PARP) inhibition therapy using olaparib has recently been approved. As global priorities continue to be epidemiological analysis of BC risk factors and early diagnosis, this review focuses on the risks and protective factors associated with TNBC. A PubMed keyword search for new knowledge on the risks and protective factors for TNBC was carried out. We also found statistical information from current online databases concerning the estimated incidence, prevalence and mortality worldwide of this cancer. Traditional risk factors for BC and TNBC are those related to reproduction such as the age of menarche, age of first birth, parity, breastfeeding and age at menopause. Attention needs to be paid to familial BC, weight control, alcohol consumption and regular physical activity. Epidemiological studies on TNBC provide evidence for protective factors such as regular consumption of soya, seafood, green tea, folic acid and vitamin D. Potential risk factors may include night work and viral infectious ag...Continue Reading

References

Jul 31, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Amanda I PhippsChristopher I Li
Apr 15, 2009·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Katerina BouchalovaMarian Hajduch
Nov 11, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O GluzN Harbeck
Feb 15, 2011·Medical Oncology·Ting WangChristopher Cao
Mar 3, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Amanda I PhippsChristopher I Li
Sep 6, 2011·Breast Cancer Research and Treatment·Jennifer D BrooksLeslie Bernstein
Jul 13, 2012·The Cochrane Database of Systematic Reviews·Anna Dorothea WagnerSusanne Unverzagt
Jan 1, 2011·Online Journal of Public Health Informatics·Febiana HananiHiroshi Oyama
Oct 25, 2013·International Journal of Cancer. Journal International Du Cancer·Rudolf KaaksAnnekatrin Lukanova
Jul 16, 2014·Nutrition and Cancer·Eunkyung LeeJennifer J Hu
Oct 27, 2014·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Chunlin ZhangMinqiang Xie
Nov 7, 2014·Current Drug Targets·Katerina BouchalovaAlice Hlobilkova
Nov 22, 2014·Virology Journal·Andrea PianaMaria De Miglio
Dec 4, 2014·Breast Cancer Research : BCR·Anthony HowellMichelle N Harvie
Dec 17, 2014·Journal of the National Cancer Institute·J de BatlleI Romieu
Jan 27, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Katerina BouchalovaZdenek Kolar
Mar 1, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Anne K SwisherLinda Vona-Davis
Mar 24, 2015·Molecular and Clinical Oncology·Chafika MazouniPierre-Marie Martin
Apr 17, 2015·BMJ Open·Torbjörn ÅkerstedtKristina Alexanderson
Oct 28, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F IslamiM Weiss
Jan 23, 2016·Cancer Causes & Control : CCC·Rachel L AtkinsonAbenaa M Brewster
Feb 3, 2016·Cancer Causes & Control : CCC·Oluwole A BabatundeJames R Hebert
Feb 6, 2016·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Fabiola GiudiciFabrizio Zanconati
Mar 17, 2016·Infectious Agents and Cancer·Jong-Myon Bae, Eun Hee Kim
May 1, 2016·International Journal of Cancer. Journal International Du Cancer·Ying LiuGraham A Colditz
Jul 22, 2016·Addiction·Jennie Connor
Aug 18, 2016·The Breast Journal·Sivan AgranatRinat Yerushalmi
Sep 25, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Paluch-ShimonUNKNOWN ESMO Guidelines Committee
Nov 1, 2016·Nutrition and Cancer·Yukyung GoYongsoon Park
Oct 21, 2016·Journal of the National Cancer Institute·Ruth C TravisValerie Beral
Dec 21, 2016·Breast Cancer Research : BCR·Natsue UehiroMasakazu Toi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.